Following positive trial data , retatrutide, a new peptide therapy for addressing adult-onset metabolic disorder, has secured regulatory approval from Great Britain's Drug and Regulatory Agency ( MHRA https://shopretatrutidepeptide.com/category/retatrutide-peptide/